Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
4 trials match this view; 13 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 258 across 4 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Countries with reported trial locations
Sponsors recorded in this index
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialAdvanced Cancer · Demoralization · Existential Distress · Psychological Distress | University of Calgary PHASE2 | Not yet recruiting Registry updated 2026-09-02 | 60 ESTIMATED | 2026-10-30 2027-12-20 2027-12-31 | |
| An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal CancersPancreas Cancer · Biliary Tract Cancer · Psychological Distress · Gastrointestinal Cancer | University of Nebraska PHASE1 | Completed Registry updated 2026-08-19 | 18 ACTUAL | 2023-04-10 2025-11-17 2025-11-17 | |
| PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialPsychological Distress | Bruyère Health Research Institute. PHASE3 | Recruiting Registry updated 2026-07-10 | 120 ESTIMATED | 2026-01-28 2027-08 2027-09 | |
| Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)Palliative Care · Pain · Anxiety · Depression · Demoralization · Psychological Distress · Quality of Life · Caregiver Burden · Fear of Death · Existential Distress | University Hospital, Basel, Switzerland PHASE2 | Recruiting Registry updated 2026-04-29 | 60 ESTIMATED | 2024-06-09 2027-09 2028-05 |
Reported research facilities
Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada
Providence Care HospitalKingston, Ontario, Canada
University of Nebraska Medical CenterOmaha, Nebraska, United States
William Osler Health SystemBrampton, Ontario, Canada
St. Joseph's HealthcareLondon, Ontario, Canada
South Lake Regional Health CentreNewmarket, Ontario, Canada
Bruyere HealthOttawa, Ontario, Canada
The Ottawa HospitalOttawa, Ontario, Canada
McGill University Health CentreMontreal, Quebec, Canada
University Hospital Basel, Division of Clinical Pharmacology and ToxicologyBasel, Switzerland
University Hospital Geneva, Palliative medicine departmentCollonge-Bellerive, Switzerland
Spital Uster AG, Division of Internal MedicineUster, Switzerland
University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative CareZurich, Switzerland
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.